The Swedish health tech company Encare has secured funding of EUR 1.5 million to support the company’s continued expansion, product development, and entrance into new international markets. Encare’s SaaS solution supports healthcare providers in implementing best practices for surgical care to improve patient outcomes. Existing shareholders, together with some new, through the Sciety network, took part in the financing round.
Encare offers an interactive SaaS solution that enhances surgical outcomes, minimizes complications, and ultimately saves lives. The innovative solution empowers healthcare providers to adhere to international treatment guidelines throughout the entire patient care continuum—from initial diagnosis and preparation to surgery and rehabilitation. By implementing these guidelines, known as ERAS® (Enhanced Recovery After Surgery), providers can reduce complications, expedite patient recovery, and shorten hospital stays. Encare’s solution has the potential to prevent avoidable deaths and complications, resulting in significant cost savings for the global healthcare industry.
Encare has a strong market presence, serving over 150 hospitals worldwide, and has experienced remarkable growth of over 30% in the last year. The capital raised will be used to further increase revenue by expanding sales to existing customers and acquiring new customers. Additionally, Encare will prioritize product development to cater to specific market needs. This strategic development will facilitate the company’s expansion into new key international markets, including the United States.
“Thanks to the continued support from our investors, we can continue our expansion and work towards our mission to positively impact the lives of millions of patients undergoing surgery worldwide. By supporting healthcare providers in implementing best practices in surgical care, Encare can contribute to reducing the number of preventable deaths and complications during surgery,” says Rasmus Waller, CEO of Encare.